| 000 | 01493 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516062222.0 | ||
| 264 | 0 | _c20120727 | |
| 008 | 201207s 0 0 spa d | ||
| 022 | _a1578-8989 | ||
| 024 | 7 |
_a10.1016/j.medcli.2011.08.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLópez Arrieta, Jesús María | |
| 245 | 0 | 0 |
_a[Myelodysplastic syndrome in the elderly: comprehensive geriatric assessment and therapeutic recommendations]. _h[electronic resource] |
| 260 |
_bMedicina clinica _cFeb 2012 |
||
| 300 |
_a119.e1-9 p. _bdigital |
||
| 500 | _aPublication Type: Consensus Development Conference; Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aBlood Transfusion |
| 650 | 0 | 4 | _aDecision Support Techniques |
| 650 | 0 | 4 |
_aDeferoxamine _xadverse effects |
| 650 | 0 | 4 |
_aErythropoietin _xadverse effects |
| 650 | 0 | 4 | _aHealth Status Indicators |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLenalidomide |
| 650 | 0 | 4 |
_aMyelodysplastic Syndromes _xdiagnosis |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aSiderophores _xadverse effects |
| 650 | 0 | 4 |
_aThalidomide _xadverse effects |
| 700 | 1 | _aDe Paz, Raquel | |
| 700 | 1 | _aAltés, Albert | |
| 700 | 1 | _adel Cañizo, Consuelo | |
| 773 | 0 |
_tMedicina clinica _gvol. 138 _gno. 3 _gp. 119.e1-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.medcli.2011.08.003 _zAvailable from publisher's website |
| 999 |
_c21263872 _d21263872 |
||